ZBH · 8-K · 20260805PR335108
Operating Cash Flow Trends
ZIMMER BIOMET HOLDINGS, INC. · 2026-08-05 · Importance 54 · Surprise 40 · From source text
Cash flow provided by operating activities increased to $1,697.1 million in 2025 from $1,499.4 million in 2024. The $197.7 million increase reflected higher sales, favorable accounts-payable timing and lower bonus and restructuring payments. Cash flow was partly reduced by acquisition-closing costs, U.S. tariffs and higher interest and tax payments. Cash used in investing activities increased to $1,975.7 million, including $1,393.2 million for the Paragon 28 and Monogram acquisitions and $52.4 million for technology-related intangible assets.
Key facts
- Cash flows provided by operating activities were $1,697.1 million in 2025 compared to $1,499.4 million in 2024. source
- Cash flows provided by operating activities increased in 2025 primarily due to higher net sales, favorable timing of accounts payable relative to 2024 and lower bonus and restructuring-related payments, partially offset by costs related to closing the Paragon 28 and Monogram acquisitions, U.S. tariffs and higher interest and tax-related payments. source
- Cash paid for leases recognized in operating cash flows for 2025: $67.9 million (2024: $57.9 million; 2023: $62.8 million). source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | realized | — | Cash flows provided by operating activities were $1,697.1 million in 2025 compared to $1,499.4 million in 2024. |
| cash | positive | realized | — | Cash flows provided by operating activities increased in 2025 primarily due to higher net sales, favorable timing of accounts payable… |
| cash | negative | realized | — | Cash flows provided by operating activities increased in 2025 primarily due to higher net sales, favorable timing of accounts payable… |